At the 42nd J.P. Morgan Healthcare Conference in San Francisco, NVIDIA CEO Jensen Huang highlighted the Innophore partnership as a key example of how generative AI is transforming drug discovery and protein engineering. The presentation showcased how Innophore’s Catalophore technology, combined with NVIDIA’s BioNeMo framework and GPU-accelerated computing, enables the rapid analysis of protein-ligand interactions at unprecedented scale. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, attracting thousands of executives and investors worldwide.

Read the full article at NVIDIA Blog